The US FDA approved Neuralink to implant its brain chip in a second patient after addressing issues from the first trial, including wires being embedded deeper into the brain.
Neuralink's first patient experienced detachment of threads causing chip malfunction, a known issue from animal testing, but now the company moves forward with applications for a new participant.
[
add
]
[
|
|
...
]